A GLP-1 weight loss plateau is a period when weight loss slows or temporarily stops during treatment, even though the medication may still be helping with appetite, food noise, portion control, and metabolic health
Its available now and helping thousands to achieve weight loss that was rarely possible with older medications
In these studies, the safety profile of retatrutide was found to be on par with that of other incretin mimetics like tirzepatide [21, 27]
GLP-1RAs have shown to improve cardiovascular health by decreasing blood pressure, stimulate differentiation of nerve cells and inhibit neuroinflammation, and inhibit hepatitis (7)
Nanoparticles (NPs) loaded with MB could offer a more effective treatment for Alzheimers and related disorders [32]
Habit-driven eating, stress responses, and food cravings rooted in dopamine pathways can persist even when true metabolic hunger is suppressed